Valeant CEO, Learning to Walk Again, Lays Out Plans to Top Staff
- `We are not sitting on any other big issues,' Pearson says
- CEO met with top executives after return from medical leave
Valeant CEO Meets With Top Execs After Medical Leave
This article is for subscribers only.
Days after his surprise return from medical leave, Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson gathered his senior managers at the company’s New Jersey offices to deliver a message: the drugmaker’s businesses were still mostly doing well, and Valeant was not going to go bankrupt.
“There is no other big shoe to drop that I am aware of,” Pearson told attendees at the March 2 meeting, according to a person who participated in the session. “To the best of my knowledge we are not sitting on any other big issues.” A Valeant spokeswoman declined to comment.